Brazil’s Fiocruz to suspend Covid-19 vaccine delivery for 2 weeks
Two active pharmaceutical ingredient (API) shipments landed in Brazil on August 25 and 30, and a new batch will be...
September 3, 2021Topic
Active Pharmaceutical Ingredient (API)
Over 60% of adult Brazilians administered first Covid-19 vaccine dose
The Ministry of Health on Monday, July 26, announced that Brazil has surpassed the mark of 60% of its population...
July 27, 2021
Brazil’s Fiocruz expects to make early delivery of 3 million vaccine doses to Health Ministry
Fiocruz expects the delivery of 3 million doses of Oxford-Astrazeneca vaccine to the National Immunization Program today, June 30
June 30, 2021
Gamma variant accounts for 90% of cases in São Paulo; Butantan begins clinical trials of Butanvac
There are 19 coronavirus variants circulating in São Paulo and the P.1, originated in Manaus, is predominant in the state
June 16, 2021
Stem cells needed for domestic production of AstraZeneca vaccine arrive in Brazil
The stem cell and virus banks that will allow the vaccine developed by the Anglo-Swedish laboratory AstraZéneca to be produced...
June 2, 2021
Fiocruz halts Covid vaccine production in Brazil for shortage of raw material
Fiocruz suspended temporarily the production of the Oxford/AstraZeneca vaccine due to a raw materia shortage, API is expected on May...
May 21, 2021
Brazil’s Health Ministry says it has distributed 90 million Covid vaccine doses
90 million Covid-19 vaccine doses have been distributed by Brazil's Health Ministry, although production is hampered by lack of API
May 19, 2021
With India now pandemic epicenter, Brazil seeks autonomy to produce vaccines
With the pandemic epicenter displaced to India, Brazil is now considering the possibility of further delays in the delivery of...
May 3, 2021
Brazil has almost 30 vaccine plants for cattle and only 2 for humans
The covid-19 pandemic has exposed a weakness in Brazil: the high dependence on imported raw materials from China for vaccine...
February 24, 2021